dacarbazine

Miscellaneous compounds - Dacarbazine was approved for medical use in the United States in 1975. It is also known as imidazole carboxamide, is a chemotherapy medication used in the treatment of melanoma and Hodgkin's lymphoma.. Reference standards of Dacarbazine API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

stdClass Object
(
    [pname] => Dacarbazine - Impurity D (Freebase)
    [catalogue_number] => PA 04 02041
    [category_ids] => ,84,
    [chemical_name] => 
    [weight] => 45.08
    [form] => C2H7N
    [cas] => 124-40-3
    [pslug] => 124-40-3-dacarbazine-impurity-d-freebase-pa0402041
    [latest_product] => 0
    [linkproducts] => 1
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 04 02041
PA 04 02041

Dacarbazine - Impurity D (Freebase)


  • Catalogue No.:PA 04 02041

  • CAS :

    124-40-3

  • Molecular Formula : C2H7N

  • Molecular Weight : 45.08

pharmaffiliates